|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Depreciation, depletion and amortization | ||||
| Amortization of acquired contract liabilities | ||||
| Amortization of acquired unfavorable contracts | ||||
| Stock-based compensation | ||||
| Loss (gain) on insurance recoveries | ||||
| Loss (gain) on disposal of assets, net | ||||
| Gain on insurance recoveries | ||||
| Non-cash loss on extinguishment of debt | ||||
| Amortization of debt issuance costs | ||||
| Acquisition earnout adjustment | ||||
| Loss (gain) on investments, net | ||||
| Provision for supply commitment charges | ||||
| Goodwill impairment | ||||
| Provision for credit losses, net of recoveries | ||||
| Impairment of long-lived assets and goodwill | ||||
| Deferred tax expense (benefit) | ||||
| Other non-cash items, net | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Inventories | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Other liabilities | ||||
| Net cash provided by operating activities | ||||
| Cash flows from investing activities: | ||||
| Acquisitions, net of cash acquired | ||||
| Investment in property, plant & equipment | ||||
| Proceeds from sale of assets | ||||
| Proceeds from insurance recoveries | ||||
| Investment in unconsolidated affiliate | ||||
| Initial investment in Flotek | ||||
| Other | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from issuance of long-term debt | ||||
| Repayments of long-term debt | ||||
| Borrowings from revolving credit agreements | ||||
| Repayments of revolving credit agreements | ||||
| Payment of debt issuance costs | ||||
| Cash settlement of vested stock awards | ||||
| Tax withholding related to net share settlement of noncontrolling interest equity awards | ||||
| Proceeds from issuance of Series A preferred stock | ||||
| Member contribution | ||||
| Payment of stock issuance costs | ||||
| Series A Preferred Stock | ||||
| Total payment of stock issuance costs | ||||
| Payment of THRC related equity | ||||
| Proceeds from issuance of common stock | ||||
| Other | ||||
| Net cash provided by (used in) financing activities | ||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | ||||
| Cash, cash equivalents, and restricted cash beginning of period | ||||
| Cash, cash equivalents, and restricted cash end of period | ||||
| Non-cash investing and financing activities | ||||
| Capital expenditures included in accounts payable | ||||
| Supplemental cash flow information: | ||||
| Cash payments for interest | ||||
| Cash payments for income taxes | ||||
Loading...
